Elegen

Elegen is a synthetic biology company that has developed ENFINIA™, the world's only entirely cell-free platform for rapid, high-quality DNA production. Using patented microfluidic synthesis, AI, and robotics, Elegen delivers long, clonal-quality, high-complexity DNA — including linear, plasmid, and IVT-ready formats — in 6 to 8 business days with 99.999% per-base accuracy. Unlike traditional approaches that require bacterial cloning and colony screening, Elegen's cell-free process eliminates bioburden, recombination, and foundry dependencies. ENFINIA DNA serves applications in cell and gene therapy, mRNA vaccines, personalized cancer vaccines, and protein expression, enabling faster and more reliable development of next-generation biologics.